Asterias Biotherapeutics to Present at Upcoming Conferences
Sep 06, 2017 11:01 am UTC| Business
FREMONT, Calif., Sept. 06, 2017 -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that members of the Company’s management team will...
Curis to Present at the Baird 2017 Global Healthcare Conference
Sep 06, 2017 11:01 am UTC| Business
LEXINGTON, Mass., Sept. 06, 2017 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today...
Tonix Pharmaceuticals to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
Sep 06, 2017 11:00 am UTC| Business
NEW YORK, Sept. 06, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, announced today...
T2 Biosystems Announces Collaboration with CDC to Detect Emerging Superbug Candida auris
Sep 06, 2017 11:00 am UTC| Business
CDC to Utilize T2Dx Instrument for Testing of Patient Samples and Monitoring Hospital Environments New Application of T2MR Technology for Detection of Candida auris in Patient Skin, Patient Blood and Hospital...
Sep 06, 2017 11:00 am UTC| Business
AUSTIN, Texas, Sept. 06, 2017 -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases...
Lightbridge and AREVA NP Sign Binding Agreement for U.S. Joint Venture for Advanced Nuclear Fuel
Sep 06, 2017 11:00 am UTC| Business
RESTON, Va., Sept. 06, 2017 -- Lightbridge Corporation (NASDAQ:LTBR) and AREVA NP in North America (AREVA Inc.), signed a binding Heads of Terms Agreement for a joint venture (JV) that summarizes all material terms and...
Collegium to Present at Upcoming Investor Conferences
Sep 06, 2017 11:00 am UTC| Business
CANTON, Mass., Sept. 06, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will present at the following investor conferences in September: The 19th Annual Rodman Renshaw Global...